TOUYUN BIOTECH News

Touyun Biotech Expands Into Vegan Food Markets

TipRanksNov 20 20:19

touyun biotech (01332) has expanded the new application range and space for the production of chlorella, and has started entering the artificial fish, shrimp, and plant milk markets.

Touyun Biotech (01332) announced that on November 20, 2024, its wholly-owned subsidiary shanxi Touyun Biotech...

Zhitong FinanceNov 20 20:05

touyun biotech (01332) issued a total of 0.279 billion share purchase rights.

touyun biotech (01332) announced that as of September 30, 2024, the company, in accordance with the resolutions adopted on June 2, 2022...

Zhitong FinanceSep 30 18:28

TOUYUN BIOTECH: INTERIM REPORT 2024

HKEXSep 26 17:43 · Announcements

The performance of touyun biotech (01332.HK) narrowed its losses in the first half to 47.97 million yuan.

touyun biotech (01332.HK) announced its interim performance for the six months ending in June, with revenue recording 73.05 million yuan, a 30% year-on-year decrease. The loss narrowed from 83.95 million yuan in the same period last year to 47.97 million yuan, with a loss per share of 1.71 cents. No interim dividends will be distributed.

AASTOCKSAug 25 16:32

Touyun Biotech Group Reports Narrower Half-Year Loss

TipRanksAug 23 19:38

TOUYUN BIOTECH: INTERIM RESULTSFOR THE SIX MONTHS ENDED 30 JUNE 2024

HKEXAug 23 19:14 · Announcements

Touyun Biotech Schedules Key Financial Meeting

TipRanksAug 9 17:26

Touyun Biotech (01332.HK) plans to hold a board of directors meeting on August 23 to approve the mid-term performance.

Touyun Biotech (01332.HK) announced that the board of directors meeting will be held on August 23, 2024 (Friday), to approve the publication of the interim performance announcement of the company and its subsidiaries for the six months ended June 30, 2024, and consider the distribution of interim dividends.

Gelonghui FinanceAug 9 17:02

China Touyun Tech Widens Loss in 2023 Amid Lower Sales Orders

MT NewswiresApr 30 17:05

TOUYUN BIOTECH: Annual Report 2023

HKEXApr 29 22:35 · Announcements

Touyun Biotech (01332) released annual results, losses attributable to shareholders of 269 million yuan, an increase of 35.78% year-on-year

According to the Zhitong Finance App, Touyun Biotech (01332) announced its annual results for the year ended December 31, 2023. The group achieved gross profit of HK$55.99 million during the period, a year-on-year decrease of 56.13%; shareholders' losses of 269 million yuan, an increase of 35.78% over the previous year; and a basic loss of 9.58 HK cents per share. According to the announcement, for the year ended 31 December 2023, the Group obtained revenue of approximately HK$198.6 million (2022: HK$315.8 million), a decrease of approximately 37.1% compared to last year. The decrease in turnover was mainly due to a decrease in sales orders for packaged products.

Zhitong FinanceMar 29 00:42

TOUYUN BIOTECH: ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED 31 DECEMBER 2023

HKEXMar 28 21:59 · Announcements

Touyun Biotech (01332.HK) held a board meeting on March 28 to approve publication of annual results

Gelonghui, March 14, 丨 Touyun Biotech (01332.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to approve (among other things) the publication of the annual results announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider the payment of a final dividend.

Gelonghui FinanceMar 14 16:50

TOUYUN BIOTECH: INTERIM REPORT 2023

HKEXSep 28, 2023 17:29 · Announcements

Touyun Biotech (01332) Announces Interim Results, Shareholders' Share of Loss of HK$83.951 million narrowed 4.67% year-on-year

Touyun Biotech (01332) announced its interim results for the six months ended June 30, 2023. The group collected during the period...

Zhitong FinanceAug 25, 2023 22:08

TOUYUN BIOTECH: INTERIM RESULTSFOR THE SIX MONTHS ENDED 30 JUNE 2023

HKEXAug 25, 2023 22:02 · Announcements

Tuyun Biotech (01332.HK) will hold a board meeting on August 25 to approve the interim results

On August 11, GLONGWI | TOYUNBIO (01332.HK) announced that the company will hold a board meeting on August 25, 2023 to approve the publication of the company and its subsidiaries's interim results announcements for the six months ended June 30, 2023, and consider the payment of interim dividends.

Gelonghui FinanceAug 11, 2023 18:26

Tian Uzawa sold 220,000 common shares of Touyun Biotech (01332.HK) worth approximately HK$114,400

According to reports on June 8, according to documents disclosed by the Hong Kong Stock Exchange on June 8, Tian Yuze sold $220,000 common shares of Tooyun Biotech (01332.HK) at an average price of HK$0.502 per share on June 6, worth about HK$114,400. After the sale, Tian Yuze recently held 148 million shares, with a good position ratio of 5.26%. The transaction involved another related party: Tauze. Photo Source: Stock Exchange's equity disclosure (partial table of this incident) What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their listed shares

Futu NewsJun 8, 2023 17:03

Tian Yuze sold 120,000 common shares of Touyun Biotech (01332.HK) worth approximately HK$63,800

According to reports on June 5, according to documents disclosed by the Hong Kong Stock Exchange on June 5, Tian Yuze sold $120,000 common shares of Tooyun Biotech (01332.HK) at an average price of HK$0.532 per share on May 29, worth about HK$63,800. After the sale, the latest number of shares held by Tian Yuze was 148 million shares, and the ratio of good positions dropped from 5.27% to 5.26%. The transaction involved another related party: Tauze. Photo Source: Stock Exchange's equity disclosure (partial table of this incident) What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) must

Futu NewsJun 5, 2023 17:04